Alex Warwick, 23, from North Finchley, was diagnosed with a rare and aggressive brain tumour in May 2025 while studying medicine in Liverpool.
He is seeking immunotherapy in Germany after NHS doctors advised further treatment there.
His sisters said: “Alex is the best of all of us.
“He is the kindest, funniest son, brother, boyfriend, friend and grandson, who always has time for other people and brings endless joy to all of us.
“Despite receiving this diagnosis so young and at the beginning of his adult life, he has faced it with his characteristic strength, humour and optimism.”
A fundraising campaign has raised more than £88,000 toward a £200,000 target.
Alex was studying at university when he fell ill during a dinner with friends.
His parents drove overnight to the hospital, where he underwent emergency brain surgery.
He was diagnosed with a rare high-grade glioma, a cancerous and aggressive brain tumour.
He responded well to surgery, radiotherapy and chemotherapy, but only a further three months of chemotherapy are being offered; after this, no additional treatment options will be available on the NHS and he is not eligible for any clinical trials currently under way.
The family say the NHS treatment protocol for his type of tumour was introduced 20 years ago and has changed little since then, leaving limited options for patients like Alex.
With no current cure for the condition, they say they are now seeking privately funded treatment.
Immunotherapy, which has been recommended by his medical team, is available in Germany at a cost of around £200,000.
The treatment is designed to activate the body’s immune system to target the tumour.
The family said it is grateful for the donations and plans to use all funds solely for medical treatment.
Any excess funds or gift aid will be donated to Brainstrust, the brain cancer charity supporting the family.
Alex’s sisters said they hope to give him the best possible chance of fighting the disease.
More than 2,500 supporters have donated to the fundraiser so far.
The family continues to raise awareness and funds in the hope that Alex can begin immunotherapy as soon as possible.
